Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway
Journal of Immunology Research · 2023
DOI: 10.1155/2023/3291137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2023. Verfasst von Bo Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Shanghai Pudong New Area People's Hospital, No. 490 Chuansha South Road, Pudong New Area, 201299,…. Hauptthemen laut MEDLINE: Acute Lung Injury, MicroRNAs, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Key Medical Discipline Group Construction in Shanghai Pudong New Area, Minsheng Research Project of Pudong New Area Science and Technology Development Fund, Project of Clinical Outstanding Discipline Construction in Shanghai Pudong New Area.
Abstract (Originalsprache)
Acute lung injury (ALI) is a life-threatening disease that currently lacks a cure. Although stem cell-derived small extracellular vesicles (sEVs) have shown promising effects in the treatment of ALI, their underlying mechanisms and responsible components have yet to be identified. Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a gene involved in inflammation and a potential target of miR-21-5p, a microRNA enriched in stem cell-derived sEVs. The current study investigated the role of PCSK6 in lipopolysaccharide (LPS)-induced ALI and its interaction with miR-21-5p. Notably, our results showed that PCSK6 expression was positively correlated with LPS stimulation. Knockdown of PCSK6 ameliorated LPS-induced inhibition of proliferation and upregulation of permeability in human BEAS-2B cells, whereas PCSK6 overexpression displayed the opposite effects. BEAS-2B cells were able to actively internalize the cocultured bone mesenchymal stem cell (MSC)-derived sEVs (BMSC-sEVs), which alleviated the cell damage caused by LPS. Overexpressing PCSK6, however, eliminated the therapeutic effects of BMSC-sEV coculture. Mechanistically, BMSC-sEVs inhibited PCSK6 expression via the delivery of miR-21-5p, which is directly bound to the PCSK6 gene. Our work provides evidence for the role of PCSK6 in LPS-induced ALI and identified miR-21-5p as a component of BMSC-derived sEVs that suppressed PCSK6 expression and ameliorated LPS-induced cell damage. These results reveal a novel molecular mechanism for ALI pathogenesis and highlight the therapeutic potential of using sEVs released by stem cells to deliver miR-21-5p for ALI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency and Critical Care Medicine, Shanghai Pudong New Area People's Hospital, No. 490 Chuansha South Road, Pudong New Area, 201299, Shanghai, China.
ORCID-Profile: Bo Cai, Weidong Song, Song Chen, Jie Sun, Rui Zhou, Zhen Han, Jian Wan
Förderung
- Project of Key Medical Discipline Group Construction in Shanghai Pudong New Area
- Minsheng Research Project of Pudong New Area Science and Technology Development Fund
- Project of Clinical Outstanding Discipline Construction in Shanghai Pudong New Area
Zitieren
APA
Cai, B., Song, W., Chen, S., Sun, J., Zhou, R., Han, Z., & Wan, J. (2023). Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway. Journal of Immunology Research. https://doi.org/10.1155/2023/3291137
Vancouver
Cai B, Song W, Chen S, Sun J, Zhou R, Han Z, et al. Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway. Journal of Immunology Research. 2023. doi:10.1155/2023/3291137
BibTeX
@article{Cai2023,
author = {Cai, Bo and Song, Weidong and Chen, Song and Sun, Jie and Zhou, Rui and Han, Zhen and Wan, Jian},
title = {Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway},
journal = {Journal of Immunology Research},
year = {2023},
doi = {10.1155/2023/3291137}
}
EUVIMED